Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection

European Journal of Vascular and Endovascular Surgery

Volumn 20, Issue 6, 2000, Pages 508-511

  Ghiselli, R ^b   Giacometti, A ^a   Goffi, L ^b   Cirioni, O ^a   Boccoli, G ^b   Mocchegiani, F ^a   Riva, A ^a   Scalise, G ^a   Saba, V ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

Author keywords

Antibiotics; Bacteria; Contamination; Prophylaxis; Vascular prostheses

Indexed keywords

AGAR; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BUFFER; CEFAZOLIN; CIPROFLOXACIN; DACRON; LEVOFLOXACIN; METICILLIN; OFLOXACIN; OXACILLIN; PHOSPHATE; POVIDONE IODINE; RIFAMPICIN; SODIUM CHLORIDE; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CONTAMINATION; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; DISEASE MODEL; DRUG EFFICACY; GRAFT INFECTION; IMPLANTATION; INOCULATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RAT STRAIN; STAPHYLOCOCCUS EPIDERMIDIS; STRAIN DIFFERENCE; SUBCUTANEOUS TISSUE; TISSUE CULTURE;

EID: 0034507235     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2000.1239     Document Type: Article

References (27)

1. New aspects in the molecular basis of polymer-associated infections due to staphylococci
2. The natural history of bacterial biofilm graft infection
3. Immunosuppression augments growth of graft-adherent. Staphylococcus epidermidis
4. Prophylactic antibiotics prevent bacterial biofilm graft infection
5. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron
6. The critical relationship of antibiotic dose and bacterial contamination in experimental infection
7. Prevention of graft infection by use of prostheses bonded with a rifampin collagen release system
8. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft
9. Prophylaxis of local vascular graft infection with levofloxacin incorporated into albumin-sealed dacron graft
10. Rifampicin impregnated Dacron grafts: No development of rifampicin resistance in an animal model
11. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft
12. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge
13. Prevention of vascular graft infection by sisomicin incorporated into fibrin glue
14. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus
15. In-vitro activity of ofloxacin, levofloxacin and D-ofloxacin against staphylococci
16. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci
17. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations
18. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin
19. Levofloxacin selects fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus less frequently than ciprofloxacin
20. Observations on the risk of resistance with the extended use of vancomycin
21. Epidemiology, appropriateness, and cost of vancomycin use
22. Emergence of vancomycin resistance in coagulase-negative staphylococci
23. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis
24. Increasing resistance of Staphylococcus aureus to ciprofloxacin
25. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus
26. Trends in bacterial resistance to fluoroquinolones